区域一体化与健康权的有效实现：中部非洲经济与货币共同体（CEMAC）药品流通的法律框架

本研究探讨共同体法所规定的药品自由流通监管体系，重点分析实现有效健康保护所需的法律和制度条件，以防范假药或不合格药品。研究指出，各国开展区域合作对于改进药品政策、保障个人健康权至关重要。

Job description: Project description: Pharmaceuticals have a special importance in contemporary public policy. At the crossroads of public health imperatives, economic demands, health sovereignty concerns, and globalization dynamics, they constitute a legal subject whose regulation now extends well beyond national borders. Every stage of their lifecycle - from research and manufacturing to potential market withdrawal - is governed by rules sharing a common goal: enforcing the effectiveness of individual right to health through access to safe, available, and quality medicines. In the era of trade internationalization, the globalization of pharmaceutical supply chains, and increasingly stringent health safety requirements, pharmaceutical regulation can no longer be viewed solely at the level of individual states. Risks associated with the circulation of falsified or substandard medicines, supply difficulties, the emergence of new health threats, and the need for continuous post-market surveillance have fundamentally reshaped the mechanisms of this regulation. Public health protection now operates within a sphere that transcends national borders, calling for a legal response based on cooperation, coordination, and regional integration. It is against this backdrop that a genuine body of Community law on medicines has gradually emerged; its ambition is no longer merely to harmonize national legislation, but to build a common legal framework that guarantees a high level of health protection. This trend toward integration is currently evident in several African regions. Faced with shared challenges—particularly regarding access to medicines, as well as their quality and safety—African states have progressively developed mechanisms for cooperation and the alignment of their pharmaceutical policies. This development is part of broader initiatives led at the continental level by the African Union, aimed at strengthening pharmaceutical regulatory systems and fostering better coordination between national and regional authorities. However, significant disparities persist among states regarding institutional capacity as well as human, technical, and financial resources. The choice of medicinal products as the subject of study aligns with this scientific objective. Among all health products, medicinal products are subject to the most advanced and strictly regulated legal framework. They encapsulate the key challenges facing any legal integration process: the harmonization of standards, the interplay between Community and national legal orders, cooperation among regulatory authorities, the monitoring of rule enforcement, and the guarantee of effective public health protection. As such, they offer a particularly relevant case study for examining the conditions required for the effectiveness of Community law and the mechanisms capable of strengthening its implementation in the long term. This research is conducted within this framework. By examining the legal, institutional, and practical conditions surrounding the implementation of the free movement of medicines, as well as the key factors that may explain its limitations, it aims to assess its contribution to the realization of the individual right to health, as recognized by universal and regional international conventions.

Profile and skills required: Master of Law (public law or international law or business law or regional integration law...) Candidate mut be interested in comaprative law as well as legal theory. Niveau de français requis: Compétent/Courant: Vous pouvez utiliser la langue avec aisance et facilité en argumentant sur des sujets complexes.